Comparing pneumococcal vaccines in a high risk population: a randomised controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea [ 2015 - 2018 ]

Research Grant

Researchers: A/Pr Peter Richmond (Principal investigator) ,  A/Pr Deborah Lehmann ,  A/Pr Peter Jacoby ,  Dr Lea-Ann Kirkham ,  Dr William Pomat

Brief description Pneumococcal disease is a major cause of pneumonia and meningitis in infants in developing countries in particular resulting in an estimated 800,000 deaths each year. This project will study how well pneumococcal vaccines perform in 260 high-risk infants in Papua New Guinea. We will examine how well the vaccines stimulate protective immunity and reduce babies carrying the pneumococcal bacteria in their nose and how long this immunity lasts for. The study will inform global immunisation policy.

Funding Amount $AUD 1,042,670.15

Funding Scheme Project Grants

Notes Standard Project Grant